CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
Filters
17 research outputs found
Effects of IFN-β1a and IFN-β1b treatment on the expression of cytokines, inducible NOS (NOS type II), and myelin proteins in animal model of multiple sclerosis
Author
A Aguzzi
A Compston
+76 more
A Holz
A Pautz
A Stępień
Adam Stepień
AH Cross
AH Cross
AK Nunes
B Nazliel
B Popko
BD Trapp
Beata Dąbrowska-Bouta
C Lucchinetti
C Raposo
C Schneider
C Stadelmann
CF Brosnan
CP Marques
DO Willenborg
E Molina-Holgado
European Study Group on Interferon β-1b in Secondary Progressive MS
F Antonetti
G Comi
G Comi
G Giovannoni
G Giovannoni
G Stoll
G Sulkowski
Grzegorz Sulkowski
H Wekerle
HH Salama
HL Weiner
HP Hartung
J Imitola
J Río
J Zielasek
JE Merrill
JJ Graber
JR Kanwar
JS Beckman
Józef Langfort
K Bendfeldt
K Bendfeldt
KG Kahl
KP Johnson
KW Selmaj
M Kapadia
M Kerschensteiner
M Sospedra
M Tiberio
M Wender
Małgorzata Chalimoniuk
MJ Groom
MK Sharief
N Tanuma
Natalia Lubina-Dąbrowska
P Guthikonda
P Rieckmann
R Aharoni
R Meyer
R Zivadinov
RC Veen Van der
RM Ransohoff
S Ireland
S Ljubisavljevic
SR Ruuls
ST Dheen
T Asakawa
T Brenner
T Hoang
T Shin
UK Laemmli
V Calabrese
V Navikas
V Navikas
Y Liu
Y Okuda
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
Get PDF
Crossref
Interferon antibodies: do they alter the beneficial effects of beta-interferon upon relapse rate in multiple sclerosis?
Author
Bertolotto A
Bornstein MB
+17 more
European Study Group on Interferon b-1b in Secondary Progressive MS.
Hartung HP
Jacobs LD
Johnson KP
Panitch H
Peter Rudge
Polman C
Pozzilli C
PRISMS (Prevention of Relapses and Disability by Interferon b-1a Subcutaneously in Multiple Sclerosis) Study Group
Rudick RA
Sorensen PS
SPECTRIMS (Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon b-1a in Multiple Sclerosis) Study Group
The IFNB Multiple Sclerosis Study Group
The IFNB Multiple Sclerosis Study Group
The Once Weekly Interferon for MS Study Group (OWIMS)
Wolinsky JS
Yudkin PL
Publication venue
'SAGE Publications'
Publication date
Field of study
No full text
Crossref
Technical note: the comparison of hypointense lesions from ‘pseudo-T1’ and T1-weighted images in secondary progressive multiple sclerosis
Author
Bland JM
D H Miller
+10 more
European Study Group on interferon b-1b in secondary progressive MS.
G J Barker
Kidd D
Kurtzke JF.
P D Molyneux
Paolillo A
S J Hickman
van Waesberghe JH
van Walderveen MAA
Zar JH.
Publication venue
'SAGE Publications'
Publication date
Field of study
No full text
Crossref
Real-life impact of early interferonβ therapy in relapsing multiple sclerosis
Author
Austin
Comi
+36 more
Confavreux
D'Agostino
D'Agostino
De Stefano
De Stefano
European Study Group on Interferon Beta-1b in Secondary Progressive MS
Jacobs
Jacobs
Kappos
Kappos
Kern
Kinkel
Kuhlmann
Kurtzke
Kurtzke
Lin
McDonald
Mechati
Normand
Noseworthy
O'Riordan
Poser
PRISMS (Prevention of Relapses and Disability by Interferon b-1a Subcutaneously in Multiple Sclerosis) Study Group
Rubin
Runmarker
Schwid
Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-Beta-1a in MS (SPECTRIMS) Study Group
The IFNB Multiple Sclerosis Study Group
The PRISMS (Prevention of Relapses and Disability by Interferon-b-1a Subcutaneously in Multiple Sclerosis) Study Group
Tintoré
Trapp
Trojano
Trojano
Trojano
Weinshenker
Yanovitzky
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
The pathogenesis of multiple sclerosis: is it really a primary inflammatory process?
Author
Bitsch A
Brex PA
+38 more
Coles AJ
Comi G
Confavreux C
Dalton CM
de Jong BA
De Stefano N
Ebers GC.
European Study Group on Interferon beta-1b in Secondary Progressive MS.
European Study Group on Interferon beta-1b in Secondary Progressive Mutiple Sclerosis
F G Maggs
Ferguson B
Gravel C
Ingle GT
J Palace
Karlik S
Kremenchutzky M
Li DK
Liu C
Lucchinetti C
Moalem G
Multiple Sclerosis Collaborative Research Group
Neumann H.
North American Study Group
Paolillo A
Parry A
PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group
Rapalino O
Rice GPA
Rocca MA
Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-beta-1a in MS (SPECTRIMS) Study Group
Serpe CJ
Streit WJ
The Copolymer 1 Multiple Sclerosis Study Group
The IFNB Multiple Sclerosis Study Group
The Multiple Sclerosis Collaborative Research Group (MSCRG)
Thompson AJ
Trapp BD
Yan Q
Publication venue
'SAGE Publications'
Publication date
Field of study
No full text
Crossref
Quality of life during the first 6 months of interfiron-beta treatment in patients with MS.
Author
B Jelles
B MJ Uitdehaag
+18 more
C H Polman
European Study Group on interferon beta-1b in secondary progressive .MS
J HA Arnoldus
J Killestein
Jacobs LD
Kurtzke JF.
L EMA Pfennings
Montgomery S
Neilley LK
Nortvedt MW
Nortvedt MW
Paty DW
Poser CM
PRISMS study group
Rice GP
Schwartz CE
The IFNB Multiple Sclerosis Study Group
Ware JE
Publication venue
Publication date
01/01/2000
Field of study
No full text
Crossref
Interferon-beta treatment for patients with multiple sclerosis: the patients' perceptions of the side-effects
Author
A Gardulf
Costello K
+19 more
European Study Group on Interferon b-1b in secondary progressive .MS
Gardulf A
Gardulf A
Gardulf A
K Gottberg
Keating MM
Krupp LB.
Lublin FD
McCorkle R
Mohr DC
Munschauer FE
Neilley LK
PRISMS Study Group (Prevention of Relapses and Disability by Interferon b-1a subcutaneously in Multiple Sclerosis Study Group)
S Fredrikson
Schapiro RT.
The IFNB Multiple Sclerosis Study Group
The IFNB Multiple sclerosis study group and the University of British Columbia MS/MRI analysis group
Walther EU
Whitlock FA
Publication venue
'SAGE Publications'
Publication date
Field of study
No full text
Crossref
International consensus statement on the use of disease-modifying agents in multiple sclerosis
Author
B Brochet
Comi G
+31 more
Comi G.
De Stefano N
European Study Group on Interferon b-1b in Secondary Progressive MS.
Ferguson B
Freedman MS
G Comi
Goodkin DE
IFNB Multiple Sclerosis Study Group
IFNB Multiple Sclerosis Study Group
J H Noseworthy
Jacobs LD
Jacobs LD
Johnson KP
Johnson KP
L D Blumhardt
Li DH
Liu C
M S Freedman
M Sandberg-Wollheim
McDonald WI
Miller DH
Oger J
P Soelberg Sørensen
Paty DW
Paty DW
PRISMS Study Group
Rieckmann P
Rudick RA
Simon JH
The Once Weekly Interferon for MS Study Group (OWIMS)
Trapp BD
Publication venue
'SAGE Publications'
Publication date
Field of study
No full text
Crossref
SaGA S, the Short and Graphic A bility Score: an alternative scoring method for the motor components of the Multiple Sclerosis Functional C omposite
Author
Alusi SH
C Vaney
+23 more
Cohen JA
Cohen JA
Collen FM
Cutter GR
D T Wade
Demeurisse G
European Study Group on Interferon b-1b in Secondary Progressive MS.
Fischer JS
Goodkin DE
Granger CV
Hoogervost ELJ
Katzman R
Kurtzke JF.
Perry J
Provinciali L
Rudick R
S Vaney
Schwid SR
Schwid SR
Uitdehaag BMMJ
Wade DT.
Whitaker JN
Wiles CM
Publication venue
'SAGE Publications'
Publication date
Field of study
No full text
Crossref
Disease-Modifying Treatment in Progressive Multiple Sclerosis
Author
A Lugaresi
A Paolillo
+79 more
A Tourbah
AE Warrington
AJ Coles
AJ Coles
AJ Green
Anne Haney Cross
B Brochet
BD Trapp
British And Dutch Multiple Sclerosis Azathioprine Trial Group
BZ Chaudhry
C O’Leary
CL Helliwell
CM Rice
D Cadavid
D Kremer
D Ontaneda
D Pöhlau
DE Goodkin
DH Mahad
DKB Li
E Alvarez
E Demicheva
European Study Group on Interferon β-1b in Secondary Progressive MS
F Barkhof
F Martinelli-Boneschi
F Mei
F Sedel
F Sedel
FD Lublin
FD Lublin
FD Lublin
G Giovannoni
GPA Rice
H Lassmann
HP Hartung
HP Hartung
J Chataway
J Lorscheider
J Zajicek
JA Cohen
JH Noseworthy
JH Noseworthy
JM Frischer
John Robert Ciotti
JR Christensen
JS Wolinsky
K Hawker
K Schreiber
L Kappos
L Kappos
L Mantia La
M Komori
MS Freedman
O Andersen
OR Hommes
P Connick
P McCroskery
P Vermersch
PS Sorensen
R Kapoor
R Magliozzi
R Reynolds
R Spain
S Mi
S Wang
S Zhornitsky
S Zhornitsky
Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-beta-1a in MS (SPECTRIMS) Study Group
SM Leary
SR Schwid
T Derfuss
The Canadian Cooperative Multiple Sclerosis Study Group
The Multiple Sclerosis Study Group
The North American Study Group on Interferon beta-1b in Secondary Progressive MS
VA Desmukh
VK Harris
X Montalban
X Montalban
X Montalban
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
1
2